NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Preanalytical evaluation of serum 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 measurements using LC-MS/MS.

Author(s): Mochizuki A, Kodera Y, Saito T, Satoh M, Sogawa K, Nishimura M, Seimiya M, Kubota M, Nomura F

Publication: Clin Chim Acta, 2013, Vol. 420, Page 114-20

PubMed ID: 23123828 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of collection tube type, anticoagulant type, delayed blood separation, storage, freeze-thaw cycling, patient food consumption, and analysis method on the measurement of 25-hydroxyvitamin D3 (25OHD3) in plasma and serum from healthy patients.

Conclusion of Paper

Collection tube type, anticoagulant type, storage of uncentrifuged blood, plasma, or serum, and freeze-thaw cycling had no effects on the measurement of 25OHD3 in plasma and serum. A non-significant trend to lower 25OHD3 in specimens collected 1 h after eating a standardized meal compared to levels in specimens collected before patients ate or 2-3 h after they ate were noted. 25OHD3 levels measured by LC-MS/MS and RIA were very strongly correlated. Average 25OHD3 levels were higher in specimens from Japanese males than in specimens from Japanese females. Interference of the LC-MS/MS assay by bilirubin C, bilirubin F, hemolytic hemoglobin, chyle, and immunoglobulin M rheumatoid factor (IgM-RF) was less than 10%.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of collection tube type, anticoagulant type, delayed blood separation, storage, freeze-thaw cycling, patient food consumption, and analysis method on the measurement of 25OHD3 in plasma and serum from healthy patients. Plasma and serum were stored at -80 degrees C until analysis.

    Summary of Findings:

    Neither storage of blood for up to 6 h at room temperature prior to centrifugation nor storage of plasma or serum impacted the measurement of 25OHD3 in serum or plasma, regardless of light exposure during storage. Further, 25OHD3 levels in serum and plasma were not affected by up to 5 freeze-thaw cycles. While no significant effects were found based on the time of specimen collection, a trend toward lower 25OHD3 levels was noted in specimens collected 1 h after patients ate a standardized meal compared to levels in specimens collected before eating or 2 h after eating. Collection tube and anticoagulant type had no effects on 25OHD3 measurements. 25OHD3 levels measured by LC-MS/MS and RIA were very strongly correlated (r=0.947) with RIA giving a positive bias of 4 ng/mL. Average 25OHD3 levels were higher in Japanese males than in females (25.5 ng/mL and 20.9 ng/mL, respectively). Interference of the LC-MS/MS assay by bilirubin C, bilirubin F, hemolytic hemoglobin, chyle, and IgM-RF was less than 10%.

    Biospecimens
    Preservative Types
    • Frozen
    Diagnoses:
    • Normal
    Platform:
    AnalyteTechnology Platform
    Steroid LC-MS or LC-MS/MS
    Steroid Radioimmunoassay
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Storage Time at room temperature 15 min
    30 min
    1 h
    2 h
    4 h
    6 h
    Storage Freeze/thaw cycling 1 cycle
    2 cycles
    3 cycles
    4 cycles
    5 cycles
    Storage Storage conditions Covered tube
    Uncovered tube
    Biospecimen Aliquots and Components Biospecimen components Spiked with bilirubin C
    Spiked with bilirubin F
    Spiked with hemolytic hemoglobin
    Spiked with chyle
    Spiked with IgM-RF
    LC-MS or LC-MS/MS Specific Technology platform RIA
    Preaquisition Patient gender Female
    Male
    Biospecimen Aliquots and Components Blood and blood products Plasma
    Serum
    Whole blood
    Biospecimen Acquisition Time of biospecimen collection Before eating
    1 h after eating
    2 h after eating
    3 h after eating
    Biospecimen Acquisition Type of collection container/solution VENOjectII plain serum tube
    Insepack serum tubes with separating gel and silica
    Insepack serum tubes for rapid coagulation
    Insepack plasma tubes with dipotassium EDTA and sodium fluoride
    Insepack plasma tubes with disodium EDTA
    Insepack plasma tubes with dipotassium EDTA
    Insepack plasma tubes with sodium heparin
    Microtainer serum tubes for neonates (gel and thrombin, accelerating clotting agent as the additive)
    Microtainer plasma tubes for neonates with dipotassium EDTA
    Serum clot activator
    Serum separator (SST)
    Biospecimen Acquisition Anticoagulant Potassium EDTA
    None
    Sodium EDTA
    Sodium fluoride
    Sodium heparin
    Biospecimen Aliquots and Components Centrifugation Centrifugation delays investigated

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...